These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 11731394)
1. Science, medicine, and the future: Cellular immunotherapy for cancer. Armstrong AC; Eaton D; Ewing JC BMJ; 2001 Dec; 323(7324):1289-93. PubMed ID: 11731394 [No Abstract] [Full Text] [Related]
2. Dendritic cells in cancer immunotherapy. 10 January 2005, London, UK. George AJ IDrugs; 2005 Feb; 8(2):104-6. PubMed ID: 15696407 [No Abstract] [Full Text] [Related]
3. Current status and future applications of cellular therapies for cancer. Copier J; Bodman-Smith M; Dalgleish A Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192 [TBL] [Abstract][Full Text] [Related]
4. Cellular immunotherapy with dendritic cells in cancer: current status. Nencioni A; Brossart P Stem Cells; 2004; 22(4):501-13. PubMed ID: 15277696 [TBL] [Abstract][Full Text] [Related]
5. Dendritic cells and immunotherapy for malignant disease. Reid DC Br J Haematol; 2001 Mar; 112(4):874-87. PubMed ID: 11298582 [No Abstract] [Full Text] [Related]
6. Immunotherapy with dendritic cells for cancer. Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615 [TBL] [Abstract][Full Text] [Related]
7. Novel perspectives on dendritic cell-based immunotherapy of cancer. Bonaccorsi I; Pezzino G; Morandi B; Ferlazzo G Immunol Lett; 2013; 155(1-2):6-10. PubMed ID: 24076312 [TBL] [Abstract][Full Text] [Related]
8. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon. Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521 [TBL] [Abstract][Full Text] [Related]
9. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors. Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441 [TBL] [Abstract][Full Text] [Related]
10. A review of dendritic cell therapy for cancer: progress and challenges. Mantia-Smaldone GM; Chu CS BioDrugs; 2013 Oct; 27(5):453-68. PubMed ID: 23592406 [TBL] [Abstract][Full Text] [Related]
11. Vaccine strategies for glioblastoma: progress and future directions. Jackson C; Ruzevick J; Brem H; Lim M Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907 [TBL] [Abstract][Full Text] [Related]
12. Personalized cancer vaccines. Jain KK Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567 [TBL] [Abstract][Full Text] [Related]
13. Cellular immunotherapy of cancer: an overview and future directions. Tao Z; Li S; Ichim TE; Yang J; Riordan N; Yenugonda V; Babic I; Kesari S Immunotherapy; 2017 Jun; 9(7):589-606. PubMed ID: 28595516 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cell activation kinetics and cancer immunotherapy. Bellone M; Camporeale A; Boni A J Immunol; 2004 Mar; 172(5):2727-8. PubMed ID: 14978067 [No Abstract] [Full Text] [Related]
15. The expanding role of immunotherapy. Martin-Liberal J; Ochoa de Olza M; Hierro C; Gros A; Rodon J; Tabernero J Cancer Treat Rev; 2017 Mar; 54():74-86. PubMed ID: 28231560 [TBL] [Abstract][Full Text] [Related]